Munar Pharma

Munar Pharma EBITDA Margin

Delisted

The EBITDA Margin of Munar Pharma (MUN.WA) as of Nov 20, 2026 is -161.74 %. In the previous year, EBITDA Margin was -60.49 % — a change of 167.37% (lower).

EBITDA Margin

-161.74 %

YoY

167.37%

Last updated:

EBITDA Margin of Munar Pharma is 2024 -161.74 % . EBITDA Margin of Munar Pharma was 2023 -60.49 % . It decreases by 167.37% lower compared to the previous year.

The Munar Pharma EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2017
-37.66 PLN
Jan 1, 2018
-2,658.87 PLN
Jan 1, 2019
-15.54 PLN
Jan 1, 2020
-69.25 PLN
Jan 1, 2021
-52.71 PLN
Jan 1, 2022
6.63 PLN
Jan 1, 2023
-60.49 PLN
Jan 1, 2024
-161.74 PLN
The Munar Pharma EBITDA Margin history
YEAREBITDA MarginYoY
-161.74 %+167.37%
-60.49 %-1,012.75%
6.63 %-112.57%
-52.71 %-23.88%
-69.25 %+345.75%
-15.54 %-99.42%
-2,658.87 %+6,960.22%
-37.66 %-1,444.92%
2.80 %-55.41%
6.28 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Munar Pharma Stock analysis

What does Munar Pharma do? No Gravity Games SA generates revenue by providing internet-related services, including content management systems, web shops, and website implementation. The company leverages its own technical infrastructure and programming resources to create and maintain specialized websites for its corporate clients. These digital assets include audiostereo.pl for audio enthusiasts, zagraj.com.pl as an online games portal, and legalneinfo.pl, which serves as an online catalogue of free software. The firm further supports application development and external software development for its corporate clients. Its portfolio extends to sport1.pl, offering information on disciplines such as football, volleyball, basketball, tennis, handball, and winter sports. Additional sites managed by the company include YOYO.pl, an independent provider of free hosting services, as well as chillisport.pl, oboe.pl, legenhit.pl, webtips.pl, xt.pl, and websonda.pl. Munar Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Munar Pharma stock

EBITDA Margin of Munar Pharma is -161.74 % in 2024.

EBITDA Margin of Munar Pharma changed from -60.49 % to -161.74 %, representing a 167.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Munar Pharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Munar Pharma with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Munar Pharma

All Key Metrics — Munar Pharma